Why the study?
Do newer antidepressants prevent relapse and recurrence of depression better than older antidepressants?
Do newer antidepressants prevent relapse and recurrence of depression better than older antidepressants?
Long-term observational data highlight the high risk of depression recurrence and the critical need for continuation and maintenance therapy.
Answers are grounded in this paper and cite their sources.
High recurrence risk supports maintenance consideration; leaves open whether newer antidepressants outperform older agents for relapse prevention.
In a 17- to 19-year follow-up study it was shown that patients admitted to the Maudsley Hospital, London (whose index episode marked their first psychiatric contact) had a 50% chance of readmission during their lifetime; those with previous admissions had a similar chance of readmission within three years. Less than one-fifth of the patients had remained well, and over one-third suffered severe chronic distress and handicap or had died unnaturally (Lee & Murray, 1988). Similar gloomy pictures were reported in a 15-year follow-up study of patients in London and Sydney (Kilohet al, 1988) and an 11-year follow-up study of patients in Montreal (Lehmannet al, 1988). As a result of such findings, much emphasis is now put on the importance of continuation and maintenance treatment of depression.
No takes yet. Share an insight, caveat, or question.
Jeffrey G. Edwards (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: